Arkolith/Insider Trading/JSPR/Form 4

Venkataraman Balaji

10% OwnerJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Feb 9, 2024
Net Buying
Open-Market Buys
$4.5M
Open-Market Sells
$0
Net Open-Market Flow
$4.5M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 8, 2024Buy(P)350K$12.95$4.5M1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-24-000337) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML